Table: Fuso Pharmaceutical -2025/26 parent results

Fuso Pharmaceutical Industries

12/05/2026 07:35

May 12 (Reuters)- 
          Fuso Pharmaceutical Industries Ltd 
          PARENT-ONLY FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)
                 Year ended       Year ended       Year to       NEXT   
              Mar 31, 2026     Mar 31, 2025   Mar 31, 2027     YEAR     
                 LATEST          YEAR-AGO        COMPANY      COMPANY   
                 RESULTS         RESULTS        FORECAST    H1 FORECAST 
  Sales           62.31           60.56           63.20        31.50    
               (+2.9 pct)       (+9.3 pct)     (+1.4 pct)    (+0.9 pct) 
  Operating        2.64            4.13            2.00       800 mln   
               (-36.1 pct)     (+110.3 pct)    (-24.2 pct)  (-35.9 pct) 
  Recurring        2.35            3.78            1.40       600 mln   
               (-37.9 pct)     (+102.4 pct)    (-40.4 pct)  (-47.0 pct) 
  Net              2.01         loss 3.29          1.30       500 mln   
                                               (-35.4 pct)  (-39.9 pct) 
  EPS          235.63 yen    loss 384.95 yen   152.25 yen    58.56 yen  
  Ann Div       90.00 yen       82.00 yen       90.00 yen               
  -Q2 Div       45.00 yen       40.00 yen       45.00 yen               
  -Q4 Div       45.00 yen       42.00 yen       45.00 yen               
  
  NOTE - Fuso Pharmaceutical Industries Ltd. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4538.T